Targeted cancer therapy with a novel low-dose rate alpha-emitting radioimmunoconjugate. - Dahle,J.; Borrebaek,J.; Jonasdottir,T.J.; Hjelmerud,A.K.; Melhus,K.B.; Bruland,Ø.S.; Press,O.W.; Larsen,R.H. (Blood, 2007)